Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatmen...( -Here to Help(TM) a new support progr...),Health

-Here to Help(TM), a new support program designed to improve treatment outcomes for patients dependent on prescription painkillers or heroin, from Reckitt Benckiser Pharmaceuticals-

RICHMOND, Va., May 18 /PRNewswire/ -- Reckitt Benckiser Pharmaceuticals has launched Here to Help(TM), an unique patient support program designed to improve outcomes for people in opioid dependence treatment with SUBOXONE(R) (buprenorphine HCl/naloxone HCl dihydrate [2 mg/0.5 mg and 8 mg/2 mg]) C-III Sublingual Tablets. By focusing on coaching and education of patients and caregivers, Here to Help(TM) is designed to assist patients in overcoming the barriers that often prevent them from being successful in treatment for prescription opioid painkiller or heroin dependence.

Although approximately 1.7 million people in the United States are affected by opioid dependence, it is a treatable brain disease that is largely unrecognized and often undertreated(1). The only FDA-approved controlled medicines that can be prescribed to treat opioid dependence in a doctor's private office are SUBOXONE(R) and SUBUTEX(R) (buprenorphine HCl [2 mg and 8 mg]) C-III Sublingual Tablets.

The Here to Help(TM) Program, supports patients in three main ways:

1. Providing personal assistance from a Care Coordinator in finding a physician who is able to treat the patient with SUBOXONE(R). Here to Help(TM) will also facilitate patients' gaining access to other critical professional services, such as psychosocial support, across the entire continuum of care.
2. Offering Care Coaches to provide personal support to patients through a series of outbound phone calls over the critical first 12 weeks of treatment; providing motivation, education, and assistance.
3. Presenting online tools and resources at